Autoantibodies to GAD65 (GAD-Abs) occur in type 1 diabetes (T1DM), latent autoimmune diabetes in adults (LADA) and autoimmune polyendocrine syndrome type 1 (APS1) as a marker of pancreatic destruction [3–6]. Here, GAD1 is linked to autoimmune polyendocrine syndrome type 1.